Concepedia
2
Publications
196
Citations
H-Index
2018
Active since
Affiliations
Amgen (Germany)(Current)
Universität Hamburg
University Cancer Center Hamburg
University Medical Center Hamburg-Eppendorf
Eva-Maria Grossjohann is an author at Amgen (Germany).
Publications per year
2018–2019
Immune checkpoints PVR and PVRL2 are prognostic markers in AML and their blockade represents a new therapeutic option
Hauke Stamm, Felix Klingler, Eva-Maria Grossjohann et al. · Oncogene · 2018 · 106 citations · Full text
Targeting the TIGIT-PVR immune checkpoint axis as novel therapeutic option in breast cancer
Hauke Stamm, Leticia Oliveira‐Ferrer, Eva-Maria Grossjohann et al. · OncoImmunology · 2019 · 90 citations · Full text
Rows per page
1–2 of 2